Explore

Experts Recommend Vegan and Vegetarian Diets for Natural Cholesterol Reduction

Experts Recommend Vegan and Vegetarian Diets for Natural Cholesterol Reduction

Experts Recommend Vegan and Vegetarian Diets for Natural Cholesterol Reduction

Infant Heart Failure: Causes, Symptoms, and Treatment in the U.S.

Infant Heart Failure: Causes, Symptoms, and Treatment in the U.S.

Heart failure in infants is a serious condition where the heart cannot pump enough blood to meet the body's needs, impacting the growth and development of vital organs. In the U.S., congenital heart disease is the leading cause, accounting for 47.6% of cases in neonates and 47.5% in infants. These structural problems, such as holes or narrow valves, force the heart to work harder, leading to congestive heart failure in approximately 20% of affected children. Cardiomyopathy, a condition affecting the heart muscle itself, also contributes to neonatal heart failure, with an incidence rate of about 8 out of 100,000 babies under one year. Early detection is crucial, as neonates face the highest mortality risk from heart problems. Symptoms can be subtle, including rapid breathing (tachypnea), feeding difficulties, excessive sweating during feeding, poor weight gain, irritability, and an enlarged liver (hepatomegaly). Diagnosis involves a detailed physical examination, vital sign monitoring, and advanced imaging ...

Rockefeller University Researchers Discover Sprinting's Unique Molecular Impact Compared to Moderate Exercise

Rockefeller University Researchers Discover Sprinting's Unique Molecular Impact Compared to Moderate Exercise

Researchers at Rockefeller University have found that short bursts of intense sprinting trigger a significantly different and more rapid molecular response in the body compared to prolonged moderate exercise. A study revealed that just three minutes of all-out sprinting (six 30-second sprints) altered nearly a quarter of the proteins measured in the blood immediately after exercise. In contrast, 90 minutes of continuous moderate cycling affected less than 0.25% of proteins. Moderate treadmill running impacted more proteins than cycling but still considerably fewer than sprinting. The sprint workout also changed over 200 metabolites and rapidly increased levels of proteins associated with blood vessel growth, tissue remodeling, and hormonal signaling. These proteins often entered the bloodstream through ectodomain shedding, a fast cell-signaling process. Human fat cells exposed to blood after sprinting showed widespread changes in gene activity related to fuel processing, hormone response, and nutrient dete...

Underserved Communities Face Significant Delays in Cancer Treatment Initiation, Study Reveals

Underserved Communities Face Significant Delays in Cancer Treatment Initiation, Study Reveals

A qualitative study focusing on breast cancer patients in an underserved urban community, specifically Montefiore Medical Center in the Bronx, New York, has highlighted significant disparities in the time to treatment initiation (TTI). The study, which reviewed 30 patient cases from 2019 to 2024, found that patients in under-resourced communities disproportionately experience delays in starting cancer treatment. These delays are primarily attributed to structural challenges and social determinants of health (SDOH), such as financial burdens, transportation issues, and childcare challenges. Black and Hispanic patients, in particular, experienced longer intervals to first treatment compared to White and non-Hispanic patients, with delays of 7 and 11 days longer, respectively. Uninsured patients also faced significantly longer delays for surgery and radiation treatments. While some delayed patients expressed a preference for more time to prepare mentally and logistically, the majority, including both delayed ...

U.S. Lawmakers Urge FDA to Tighten Regulations on Chinese Clinical Trial Data Following Patient Deaths

U.S. Lawmakers Urge FDA to Tighten Regulations on Chinese Clinical Trial Data Following Patient Deaths

Two Republican U.S. Representatives, John Moolenaar of Michigan and Ben Cline of Virginia, have sent a letter to the acting commissioner of the U.S. Food and Drug Administration (FDA), Kyle Diamantas, demanding stricter regulations on the use of Chinese clinical trial data in U.S. drug development and approval processes. This demand follows recent reports of three patient deaths in China involving experimental gene therapies, including two children. The lawmakers highlighted concerns that the U.S. is accepting unverified Chinese clinical data, potentially exposing patients to undue risks. They specifically requested that the FDA not accept clinical trial data generated in China for Investigational New Drug (IND) applications, New Drug Applications (NDA), or Biologics License Applications (BLA), unless the trial sites have undergone an FDA on-site inspection within 12 months prior to the application submission. Additionally, they called for a comprehensive evaluation of the U.S. reliance on Chinese-initiate...

Anthony Fauci Led NIAID for 38 Years Through Multiple Health Crises

Anthony Fauci Led NIAID for 38 Years Through Multiple Health Crises

Anthony Stephen Fauci, born on December 24, 1940, in Brooklyn, New York, has dedicated over five decades to American public health. As a physician ...

FDA Publishes White Paper on Digitally Derived Measures for Clinical Investigations

FDA Publishes White Paper on Digitally Derived Measures for Clinical Investigations

The U.S. Food and Drug Administration (FDA) has released a white paper titled “Key Considerations for the Development and Use of Digitally Derived Measures for Clinical Investigations.” This document outlines important considerations for leveraging digital health technologies (DHTs) to collect data in clinical trials. The FDA emphasizes that DHTs, particularly those enhanced by artificial intelligence, can continuously capture health information in real-time and within a person's daily life, expanding beyond traditional periodic clinic visits. This initiative aligns with the FDA’s mission to protect and advance public health by supporting innovation in medical product development. The white paper aims to guide the development and use of digitally derived measures (DDMs) as outcomes in clinical investigations, advancing one of the FDA’s priorities under Public Health Pillar 1: strengthening the use of emerging technologies.

Study Links Mediterranean Lifestyle to Reduced Cardiovascular Risk and Mortality in Type 2 Diabetes Patients

Study Links Mediterranean Lifestyle to Reduced Cardiovascular Risk and Mortality in Type 2 Diabetes Patients

A recent study published in eClinicalMedicine, utilizing data from the UK Biobank, investigated the association between adherence to a Mediterranean lifestyle and the risk of major adverse cardiovascular events (MACE) and mortality in adults with type 2 diabetes (T2D). The study followed over 3,600 adults aged 40-70 with T2D, assessing their adherence to a Mediterranean lifestyle through a modified Mediterranean Lifestyle Index (MEDLIFE). This index considered dietary patterns, physical activity, rest, and social habits. The findings indicated that higher MEDLIFE adherence was significantly associated with a reduced risk of MACE, all-cause mortality, and cardiovascular disease (CVD) mortality. Specifically, participants in the highest MEDLIFE quartile showed a 27% lower risk of MACE, a 26% lower risk of all-cause death, and a 51% lower risk of CVD death compared to those in the lowest quartile. Each two-point increase in the MEDLIFE score was linked to a 12% lower risk of MACE, a 21% lower risk of CVD mort...

New Discovery Offers Hope for Combating Drug-Resistant Fungal Infections Amid Shortage

New Discovery Offers Hope for Combating Drug-Resistant Fungal Infections Amid Shortage

Researchers from the Monash Warwick Alliance have identified gladiolin, a bacterial antibiotic, as a potential new tool in the fight against life-threatening fungal infections. This discovery is particularly significant given the global shortage of effective antifungal drugs and the rise of drug-resistant pathogens, especially those forming on medical devices. Gladiolin has been found to disarm *Candida albicans*, a common cause of severe fungal infections, by switching it from its tissue-damaging 'hyphae' form back to a less harmful 'yeast' state. The molecule achieves this by altering the fungus's metabolism, causing it to consume glucose more rapidly, thereby hindering its invasive growth. This research, published in *Current Biology*, suggests that gladiolin could enhance the efficacy of existing antifungal treatments, potentially allowing for lower, less toxic dosages. Fungal infections are a major global health concern, responsible for an estimated two million deaths annually, with limited and often ...

Trump picks White House ally Overton to lead embattled FDA

Trump picks White House ally Overton to lead embattled FDA

By Yasmeen Abutaleb WASHINGTON, Aug 19 (Reuters) - U.S.

Study Reveals Social Context as Key Factor in Lung Cancer Screening Adherence Disparities

Study Reveals Social Context as Key Factor in Lung Cancer Screening Adherence Disparities

A recent study led by Dr. Jessica H. Porembka, associate professor of radiology at UT Southwestern Medical Center, indicates that social context, rather than race or ethnicity alone, significantly influences adherence to lung cancer screening (LCS). The research, supported by an R&E Foundation Canon Medical System USA, Inc./RSNA Research Seed Grant, assessed testing-related morbidity for low-dose computed tomography (LDCT) in LCS participants, including underserved and minoritized populations. The study found that participants who were uninsured or underinsured, unemployed, or experiencing greater socioeconomic disadvantage reported higher testing-related burdens and lower physical and mental health scores. These findings suggest that structural barriers tied to social determinants of health, such as insurance coverage, financial strain, and access to care, are primary obstacles to consistent screening. The study utilized validated testing-related health surveys to gather information on patients' exam expe...

MIT Researchers Identify Caspase-1 Inhibition as Promising Strategy for Lung Cancer Prevention

MIT Researchers Identify Caspase-1 Inhibition as Promising Strategy for Lung Cancer Prevention

Researchers at MIT have identified a potential new approach to reducing lung cancer risk by targeting caspase-1, an enzyme involved in inflammation. Their findings, published in Science Advances, suggest that blocking this enzyme may suppress tumor formation before cancer becomes established. This research builds on earlier clinical observations from the CANTOS trial, which indicated that an anti-inflammatory therapy targeting interleukin-1 beta (IL-1β) led to lower rates of lung cancer. The MIT team used specialized nanosensors to monitor protease activity in genetically engineered mice predisposed to lung cancer, observing a significant increase in caspase-1 activity in mice that developed tumors. Conversely, mice treated with an IL-1β-blocking antibody showed lower caspase-1 activity and fewer tumors. Human lung fluid samples from patients with lung cancer also exhibited higher levels of caspase-1 activity compared to healthy individuals with similar smoking histories, supporting the preclinical finding...